Follow us on Twitter
twitter icon@FreshPatents


Digestive Tract patents

      

This page is updated frequently with new Digestive Tract-related patent applications.




Breath analyzer and breath test method
The present invention provides an improved breath analyzer and breath test method to determine the presence of h. Pylori in a subject's digestive tract..

Method for supporting gut health
Calcium pyruvate and derivatives or formulations thereof can be employed for supporting gut health and lessen inflammations, for example in chronic inflammatory diseases of the digestive tract, and irritable bowel syndrome. Therefore, the invention relates to the use of calcium pyruvate preparations for treating inflammatory diseases, especially of the digestive tract of humans and mammalian animals, pets and livestock.

Saponified tall oil fatty acid for use in treatment and animal feed supplements and compositions
The present invention relates to a tall oil fatty acid which is modified by saponification for use in the prevention of growth of harmful bacteria in the animal digestive tract and/or in the prevention of intestinal disorders. The invention further relates to a feed supplement and a feed composition comprising tall oil fatty acid which is modified by saponification..
Hankkija Oy


Devices and methods for weight control and weight loss
The present invention provides compositions, devices; and methods for affecting, among other things, weight loss and/or weight control, by sequestering nutrients or other compounds such as toxins from absorption in the digestive tract. The compositions, devices, and methods employ one or more members made of a compressible, absorbent matrix material.
Slendine Sa


Inhibition of methanogenesis to control wood boring insects and pestilence
A method for inhibiting methane production in the digestive tract of methanogenic archaea (e.g., termites, other wood boring pests). The inhibiting of the critical biochemical pathways specific to the methanogenic archaea is achieved by having the methanogenic archaea ingest an anti-methanogenic compound.
Environmental Intellectual Property, Inc


Intragastric device for treating obesity
A gastrointestinal device for treating obesity includes a three-dimensional porous structure configurable between a compressed pre-deployment configuration to facilitate delivery and an expanded post-deployment configuration. The porous structure includes a first opening at its proximal end and a larger second opening at its distal end.
Synerz Medical, Inc.


Method and gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation
Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include roux-en-y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy.
Covidien Lp


Method and system for detection of contraband narcotics in human digestive tract
A method for automated detection of illegal substances smuggled inside internal cavities of a passenger, e.g., as capsules. The method provides for an automated detection of narcotics hidden in a passenger's stomach area using pictures produced by an x-ray scanner.
Adani Systems, Inc.


Method of inserting treatment tool
A method of inserting a treatment tool includes: making a puncture needle project from a first channel of an endoscope and puncturing an upper digestive tract to place a distal end of a needle tube of the puncture needle inside a biliary tract while observing an ultrasound image; inserting a guide wire into the biliary tract via the needle tube and making a distal end of the guide wire extend out from a duodenal papilla into a duodenum; placing a distal end portion of the endoscope in vicinity of the duodenal papilla while keeping the distal end of the guide wire extending out from the duodenal papilla while observing a captured image; pulling the guide wire extending out from the duodenal papilla into a second channel having a raised angle of the treatment tool larger than that of the first channel; and inserting the treatment tool inside the biliary tract via the guide wire.. .
Olympus Corporation


Antibody therapeutics with local activity in the digestive tract
This invention provides methods and compositions of antibody therapeutics that are therapeutically effective in the digestive tract or below the mucosal barrier of the digestive tract but do not deliver levels of antibody to the systemic circulation that have been shown to be necessary for clinical benefit following systemic administration of antibody. This invention further describes therapeutic compositions of antibody therapeutics that are therapeutically effective in the digestive tract or below the mucosal barrier of the digestive tract but do not deliver levels of antibody to the systemic circulation that have been associated with adverse events and systemic immunosuppression following systemic administration of antibody..
Avaxia Biologics, Incorporated


Incisionless gastric bypass method & devices

A system and method for endoscopically forming an anastomosis between two naturally adjacent points in the digestive tract. The system and method utilizes elongate magnetic devices that, when connected across a tissue boundary, necrose tissue until an anastomosis forms and the devices are passed naturally.

Colon vitamin

A colon vitamin includes ingredients that are delivered to different regions of the digestive tract. A first group of ingredients which can include: vitamin d, folic acid, vitamin b2, vitamin b6, beta-carotene, selenium, curcumin, green tea extract, and a portion of the calcium serving can be in a first delivery mechanism that releases these ingredients in the stomach.

Prodrugs of urolithins and uses thereof

The compounds are effective pro-drugs for urolithins and they enable the ready delivery of urolithins to the site in the digestive tract where they can be absorbed into the body.. .

Wearable personal computer and healthcare devices

Embodiments described herein may fully integrate personal computing and health care into a wearable waistband having a length sensor, a pressure sensor, and a motion sensor; or into a wearable “mesh” having an array of sound sensors, which will create convenient and seamless access to a personal computer and biofeedback of the wearer. Such biofeedback from the waistband may include determining respiration rate, waist length, food quantity of a meal, sitting or sleep time, and frequency of visits to the bathroom.
Intel Corporation

Feed supplement and a feed composition comprising resin acid based composition

The present invention relates to a feed supplement which comprises a resin acid based composition comprising over 10% (w/w) resin acids for use in the prevention of growth of harmful bacteria in the animal digestive tract, in the prevention of intestinal disorders, in the modulation of microbial population of the animal digestive tract, in enhancing rumen fermentation, lowering rumen methane production and/or in binding toxins. The invention further relates to a use of the feed supplement and a feed composition comprising the feed supplement..
Forchem Oy

Non-invasive systems, devices, and methods for selective brain cooling

Methods, systems, and devices are disclosed for providing selective and non-selective cooling and warming of a patient. Multiple embodiments of devices are disclosed for performing rapid induction and maintenance of therapeutic hypothermia either in a hospital setting or in the field so that hypothermic treatment can be quickly instituted before significant tissue damage occurs.
Neurosave, Inc.

A feed supplement and a feed composition comprising resin acid based composition

The present invention relates to a feed supplement which comprises a resin acid based composition comprising over 10% (w/w) resin acids for use in the prevention of growth of harmful bacteria in the animal digestive tract, in the prevention of intestinal disorders, in the modulation of microbial population of the animal digestive tract, in enhancing rumen fermentation, lowering rumen methane production and/or in binding toxins. The invention further relates to a use of the feed supplement and a feed composition comprising the feed supplement..
Forchem Oy

Slow-release solid oral compositions

The present invention relates to a slow-release solid oral nutraceutical and/or pharmaceutical composition comprising: a core containing a donor of methyl groups and at least one pharmaceutically acceptable excipient, and an outer coating containing shellac and/or a pharmaceutically acceptable salt thereof, magnesium stearate, and at least one pharmaceutically acceptable excipient. The coating of said solid oral composition allows the donor of methyl groups, preferably same and/or a pharmaceutically acceptable salt thereof, to cross intact the gastric barrier and release the same in a continuous and complete manner along the entire digestive tract..
Gnosis Spa

Capsule endoscope having a self-cleaning surface and using the same

The present invention discloses a capsule endoscope and a method to prevent the capsule from being covered by a residue or mucous in a patient's digestive tract. The capsule endoscope comprises an improved surface, preventing a residue or mucous to adhere onto the surface of the capsule, and in the unlikely event that a residue or a mucous is collected by the capsule the improved surface can allow an easy and successful clean before an image is taken..

Yap protein inhibiting polypeptide and application thereof

Provided in the present invention are a yap protein inhibiting polypeptide and application thereof. In particular, the present invention obtains a key binding site of yap protein and tead, screens a polypeptide with best yap inhibitory activity and modifies the polypeptide, such as adding a disulfide linkage, replacing an amino acid, removing and/or adding (for example, adding a cell-penetrating element), and finally screens and verifies the obtaining of a series of polypeptides with yap protein activity inhibiting effect and good stability.
Bao Kang Biomedical Healthcare Inc

Inclusion complexes and methods for making the same

The invention provides novel formulations comprising a stable inclusion complex of tributyrin and a cyclodextrin. In one particular embodiment, the formulation comprises an oven dried inclusion complex of tributyrin and γ-cyclodextrin that is effective in minimizing or preventing the unpleasant taste and odor of tributyrin, thus making it suitable for oral administration and delivery to the digestive tract and intestines.
The Board Of Trustees Of The University Of Illinois

Paliurus ramosissimus (lour.) poir extract and preparation method and uses thereof

The invention belongs to the field of medicine, involving new uses of paliurus ramosissimus (lour) poir. And its extract, in particular the use of paliurus ramosissimus (lour) poir.
Sichuan Academy Of Chinese Medicine Sciences

Feed supplement and a feed composition comprising resin acid based composition

The present invention relates to a feed supplement which comprises a resin acid based composition comprising over 10% (w/w) resin acids for use in the prevention of growth of harmful bacteria in the animal digestive tract, in the prevention of intestinal disorders, in the modulation of microbial population of the animal digestive tract, in enhancing rumen fermentation, lowering rumen methane production and/or in binding toxins. The invention further relates to a use of the feed supplement and a feed composition comprising the feed supplement..
Forchem Oy

Feed supplement and a feed composition comprising resin acid based composition

The present invention relates to a feed supplement which comprises a resin acid based composition comprising over 10% (w/w) resin acids for use in the prevention of growth of harmful bacteria in the animal digestive tract, in the prevention of intestinal disorders, in the modulation of microbial population of the animal digestive tract, in enhancing rumen fermentation, lowering rumen methane production and/or in binding toxins. The invention further relates to a use of the feed supplement and a feed composition comprising the feed supplement..
Forchem Oy

Ferroporphyrin solid dispersion and preparation method therefor

Disclosed are a ferroporphyrin solid dispersion, preparation method therefor and a pharmaceutical composition comprising the solid dispersion, wherein the weight ratio of ferroporphyrin to the carrier material in the dispersion is 1:1-1:10. The solid dispersion of the present invention masks the undesirable taste of ferroporphyrin, ameliorates irritation thereof to the digestive tract, and at the same time increases the solubility thereof and improves the bioavailability thereof..
Sinotherapeutics Inc.

Device and reducing calorie intake

Devices and methods for substantially reducing the caloric efficiency of the digestive tract by capturing food being digested in the stomach 10 and/or anywhere else in the gastrointestinal (gi) tract, absorbing or encapsulating the captured food into multiple capturing members and moving such multiple capturing members containing the ingestible encapsulated food down the gi tract, practically out of reach of the gi absorption organs, thus excluding the entrapped ingredients from being involved in the digestion and\or absorption process. The device is designed for oral delivery.
Slendine Sa

Anti-inflammatory proteins and methods of use

A method and composition for reducing or alleviating inflammation in a subject is provided, including administering to the subject a therapeutically effective amount; of one or more isolated proteins respectively comprising an amino acid sequence set forth in seq id nos:1-31, or a biologically active fragment or variant thereof or combinations of these to thereby reduce or alleviate inflammation. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease..
James Cook University

Modified anti-inflammatory proteins and use

A modified ac-tmp-2 protein lacks one or a plurality of acidic c-terminal amino acids normally present in a full-length or wild-type ac-tmp-2 protein and may also lack one or a plurality of n-terminal amino acids while retaining the amino acid sequence c—s—c at or near the n-terminus. The modified ac-tmp-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject.
James Cook University

Digestive tract patency capsule

Disclosed is a digestive tract patency capsule, comprising an outer membrane (2) and a supporting material (1) which is soluble in digestive juices. The outer membrane (2) is a sealed soft capsule body made from a sustained-release enteric material, and the dissolution time of the outer membrane (2) is greater than the normal emptying time of the human digestive tract.

Interactive ngt system

Disclosed is an ngt system, the system comprises a nasogastric tube having a diameter and length configured to pass through an esophagus such that the lumen of the ngt maintains fluid communication with a portion of the digestive tract, and a digestive tract sensor operatively associated with the ngt, the digestive tract sensor configured to sense from inside the body and transmit signals in response to one or both of conditions relating to nourishment states of the digestive tract, and positioning of the ngt.. .
Art Healthcare Ltd.

Animal feed including cationic cholesterol additive and related methods

Methods and feed compositions for increasing health of agricultural animals incude administering a cationic cholesterol additive through the diet of the animal, such as through solid feed or drinking water of the animals. The method includes feeding an animal a diet comprised of a cationic cholesterol additive, such as a compound with a sterol backbone and a plurality of cationic groups attached thereto.
Brigham Young University

Iron-based montmorillonite medicament for treating hyperphosphatemia and iron-deficiency anemia, and preparation method therefor

It discloses an iron-based montmorillonite medicine for treating hyperphosphatemia and iron deficiency anaemia, and the preparation method thereof. The medicine comprises effective ingredient iron-based montmorillonite (fe-montmorillonite) which is obtained by soaking or eluting the medicinal montmorillonite by water soluble iron salt solution.
Shandong Sibangde Pharmaceutical Co., Ltd.

Probiotic bacteria comprising metals, metal nanoparticles and uses thereof

The invention relates to probiotic bacteria selected from lactic acid bacteria, such as lactobacillus and bifidobacteria, having metals and/or metal nanoparticles and to foodstuff and pharmaceutical composition having these bacteria. The invention also provides methods for obtaining these bacteria and uses of these bacteria for the treatment and prevention of mineral deficiency pathologies, as a contrast agent for the imaging of the digestive tract and for the treatment of cancer..
Biosearch, S.a.

Implantable digestive tract organ

An implantable digestive organ is provided for the transport of materials through the digestive tract and in one particular application to an artificial large bowel for replacing all or part of a colon. The prosthetic organ of one embodiment includes an outer support structure, an expandable member or members located within the support structure, and a flexible inner member forming a conduit for passage of material.
Python Medical, Inc.

Microorganism biomass for prevention and reduction of the adverse effects of mycotoxins in digestive tract

The present invention relates to microorganism biomass and a feed or food composition which can be used in preventing or reducing the adverse effects of mycotoxins in animal or human digestive tract. The biomass comprises non-living microorganism biomass obtainable by cultivating microorganism strains on a cultivation medium comprising lignocellulosic material..
Neste Oil Corporation

Nutritional supplement system

A multi-part nutritional supplement system supplies nutrients to a user at advantageous locations in the digestive tract. One type of dosage unit is formulated to release vitamin b12 in the stomach and intestines of the upper gi tract, advantageously in an amount that is greater than or at multiple levels of the dv (daily value) of vitamin b12..
Shaklee Corporation

Derivatized hyperbranched polyglycerols

Herein are provided derivatized hyperbranched polyglycerols (“dhpgs”). The dhpg comprises a core comprising a hyperbranched polyglycerol derivatized with c1c20 alkyl chains and a shell comprising at least one hydrophilic substituent bound to hydroxyl groups of the core, wherein the hyperbranched polyglycerol comprises from about 1 to about 200 moles of the at least one hydrophilic substituent.
Centre For Drug Research And Development

Microorganism biomass for prevention and reduction of the adverse effects of pathogens in digestive tract

The present invention relates to microorganism biomass and a feed or food composition which can be used in preventing or reducing the adverse effects of pathogens in animal or human digestive tract. The biomass comprises non-living microorganism biomass obtainable by cultivating microorganism strains on a cultivation medium comprising lignocellulosic material..

Application of enrofloxacin salt in preparation of oral preparation for pigs

The invention discloses application of an enrofloxacin salt in preparation of an oral preparation for pigs. The enrofloxacin salt is at least one of salts formed by enrofloxacin and metal ions, and the metal ions are zinc, copper, calcium, magnesium, iron, cobalt, manganese, chromium, silver or nickel.
Guangzhou Insighter Biotechnology Co., Ltd.

Intragastric device for treating obesity

A gastrointestinal device for treating obesity includes a three-dimensional porous structure configurable between a compressed pre-deployment configuration to facilitate delivery and an expanded post-deployment configuration. The porous structure includes a first opening at its proximal end and a larger second opening at its distal end.
Synerz Medical, Inc.

Expandable device for tissue collection from an aerodigestive body lumen

A device for obtaining tissue from the aerodigestive tract is provided. The device may have internal and external folds and a tissue collection surface for collecting a tissue sample from a body lumen, such as the nose or throat.
Adn International, Llc

Tall oil fatty acid for use in treatment and animal feed supplements and compositions

The present invention relates to a tall oil fatty acid for use in the prevention of growth of harmful bacteria in the animal digestive tractand/or in the prevention of intestinal disorders. The invention further relates to a feed supplement and a feed composition comprising tall oil fatty acid..
Hankkija Oy

Use of tall oil fatty acid

The present invention relates to use of a tall oil fatty acid in the modulation of microbial population of the animal digestive tract. The invention further relates to use of a feed supplement and a feed composition comprising tall oil fatty acid..
Hankkija Oy

Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays

This invention relates to novel rationale and methods for identifying human and primate taste-specific genes, including genes involved in salty taste perception, especially human salty taste perception, but also genes involved in sweet, bitter, umami, and sour taste perception, and genes involved in other taste cell or taste receptor related activities such as digestive function and digestive related diseases, taste cell turnover, immunoregulation of the oral and digestive tract, and metabolic regulation such as in diabetes and obesity, the genes identified using these methods, and assays for identifying taste modulators (enhancers or blockers) and potential therapeutics using these genes. These compounds have potential application in modulating (enhancing or blocking) taste perception, especially salty taste perception and as potential therapeutics.
Senomyx, Inc.

Immediate-release bolus

The subject of the invention is a veterinary product or a nutrition product intended in particular for the prevention and treatment of hypocalcaemia in ruminant animals. The product is in the form of a bolus comprising calcium chloride and an effervescent mixture.
Hy-nutrition

Use of a macrocyclic lactone for treating a complication from a papilloma virus infection

A compound is described that is selected from among macrocyclic lactones for treating and/or preventing a complication from a human papillomavirus infection. The complication to be treated and/or prevented can be selected from among malignant melanomas, skin carcinomas, in situ or invasive carcinomas, epidermoid carcinomas, bowen's disease, head and neck cancers, upper aerodigestive tract cancers, laryngeal cancers, esophageal cancers, stomach cancers, oral papillomas, pharyngeal papillomas, laryngeal papillomas, esophageal papillomas, lung cancers, intravulval neoplasias, intravaginal neoplasias, intracervical neoplasias, cervical dysplasias, cervical carcinomas, penile cancer, intrapenile neoplasias, and in situ or invasive anal carcinomas..
Galderma Sa

Digestive tract device

A digestive tract device that can reduce an indwelling-induced burden on the living body includes: a tubular portion that includes a through hole; a holding portion that is provided on a proximal end side of the tubular portion, and holds the tubular portion in the living body; and support portions and which are provided in the holding portion, and are in contact with a plurality of sites of the digestive organ of the living body, and support the holding portion in such a way that the holding portion can move in at least one direction of a circumferential direction and a longitudinal direction of the tubular portion.. .
Terumo Kabushiki Kaisha

Safely ingestible batteries

A battery for use in electronic devices and which is safely ingested into a body and a related method of making the battery. The battery includes an anode, a cathode and a quantum tunneling composite coating.

Devices and methods for treatment of obesity

A device for isolating tissue in the digestive tract including a biocompatible portion having a surface sized to cover the tissue to be isolated and also includes a plurality of micro-anchors attached to the biocompatible portion and extending from the surface, the micro-anchors sized to penetrate the mucosa of the tissue. A method for isolating tissue in the digestive tract in which an isolation element is delivered to a desired location in the digestive system; the isolation element having fixed thereto a plurality of micro-anchors.
Medical And Surgical Review, P.c.

Jejunal feeding tube and delivery system

A delivery apparatus and related method for delivering a gastrointestinal device includes a gastrointestinal device (e.g., a delivery or feeding tube) having a lumen to provide a conduit into the digestive tract, from a location external to the digestive tract. The apparatus includes an inner shaft slidably disposed within the lumen of the gastrointestinal device.
Gi Dynamics, Inc.

Liquid preparation for oral administration for use in ct colonography, and composition for imaging digestive tract

There are provided a liquid preparation for oral administration which contains barium that is likely to be mixed with residues and is less likely to be precipitated in the intestinal tract, and a liquid preparation for oral administration and a composition for imaging a digestive tract which contain barium and enable the reduction of the dose of an intestinal tract cleaning solution in a the intestinal tract pretreatment. That is, there are provided an orally administered liquid preparation which contains barium and one or more types of thickening agents selected from the group consisting of a natural polysaccharide and a cellulose-based polymer, in which the viscosity at a shear rate of 21.54 s−1 is 100 mpa·s or greater and the viscosity at a shear rate of 464.1 s−1 is 5 mpa·s to 90 mpa·s, and the particle diameter d10 which is the particle diameter when the accumulation value in a volume cumulative distribution of the barium becomes 10% is 0.30 μm to 0.80 μm and the particle diameter d90 is 1.0 μm to 10 μm; and a liquid preparation for oral administration used in ct colonography digestive tract imaging, which contains barium and a water-soluble polymer or a saline purgative agent, and is taken in an amount of 50 ml to 2000 ml all at once or in several parts over a period of time on the day before the ct colonography is performed..
Fushimi Pharmaceutical Co., Ltd.



Digestive Tract topics:
  • Digestive Tract
  • Pharmaceutically Acceptable Salt
  • Anastomosis
  • Weight Loss
  • Metabolite
  • Gastrointestinal
  • Distributed
  • Contraction
  • Contractions
  • Nitrous Oxide
  • Malformation
  • Thalidomide
  • Hypertensive
  • Paclitaxel
  • Oxaliplatin


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Digestive Tract for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Digestive Tract with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.3086

    file did exist - 2598

    2 - 1 - 51